During the past decade, Ospedale Mauriziano Umberto I conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 13 clinical trials were completed, i.e. on average, 24.5% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 10 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Mauriziano Umberto I" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 8 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Mario Negri Institute for Pharmacological Research" with 4 trials sponsored, "Amgen" with 3 trials sponsored and "Bayer" with 3 trials sponsored. Other sponsors include 51 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Mauriziano Umberto I" #1 collaborator was "Belgian Gynaecological Oncology Group" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "PharmaMar" with 2 trials as a collaborator, "AGO Study Group" with 1 trials as a collaborator and "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Mauriziano Umberto I" are "Ulcerative Colitis" (9 trials), "Ovarian Cancer" (5 trials), "Crohn Disease" (4 trials), "Fallopian Tube Cancer" (4 trials) and "Acute Myeloid Leukemia" (3 trials). Many other conditions were trialed in "Ospedale Mauriziano Umberto I" in a lesser frequency.

Most popular intervention types in "Ospedale Mauriziano Umberto I" are "Drug" (52 trials), "Other" (12 trials), "Device" (8 trials), "Procedure" (8 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Atezolizumab" (5 trials), "paclitaxel" (4 trials), "Carboplatin" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Mauriziano Umberto I" are 61 trials for "All" genders and 18 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Mauriziano Umberto I". undefined are not yet recruiting, 21 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Ospedale Mauriziano Umberto I, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Mauriziano Umberto I, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 5 trials that are defined as “Not Applicable".

Ospedale Mauriziano Umberto I has several departments that took part in Clinical trials: "Ospedale Mauriziano Umberto I - Sc Cardiologia" - 2 trials